Ill. Admin. Code tit. 77, pt. 2085 - RESEARCH
- § 2085.10 - Definitions
- § 2085.15 - Eligibility
- § 2085.20 - Authorization Procedure
- § 2085.25 - Terms and Conditions of Authorization
- § 2085.30 - Informed Consent
- § 2085.35 - Research Order Blanks for Dispensing Delta-9-THC Capsules
- § 2085.40 - Labeling Requirements
- § 2085.45 - Packaging Requirements
- § 2085.50 - Confidentiality of Cancer Chemotherapy Patients Receiving delta-9-THC Medication
- § 2085.55 - Reports and Recordkeeping
- § 2085.60 - Audits and Inspections
- § 2085.65 - Security
- Exhibit A - DAS Form 229-1, version 30
- Exhibit B - DASA Form 229-2, version 28
- Exhibit C - Special Instructions overing Research Medication Order Forms for Delta-9-Tetrahydrocannabinol, version 14
- Exhibit D - Special Instructions Covering Research Medication Labels for Delta-9-Tetrahydrocannabinol Containers, version 8
- Exhibit E - Research Order for Delta-9-Tetrahydrocannabinol, version 5
Notes
Adopted at 5 Ill. Reg. 4868, effective April 22, 1981; transferred July 1, 1984 to the Department of Alcoholism and Substance Abuse by the Alcoholism and substance Abuse Act; codified at 8 Ill. Reg. 19340; recodified from Department of Alcoholism and Substance Abuse to Department of Human Services at 21 Ill. Reg. 9319.
AUTHORITY: Implementing and authorized by Section 11 of the Cannabis Control Act [720 ILCS 550/11 ].
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.